These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19720419)

  • 1. Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes.
    Wagner J; Allen NA; Swalley LM; Melkus GD; Whittemore R
    Diabetes Res Clin Pract; 2009 Nov; 86(2):96-103. PubMed ID: 19720419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program.
    de Groot M; Marrero D; Mele L; Doyle T; Schwartz F; Mather KJ; Goldberg R; Price DW; Ma Y; Knowler WC;
    Psychosom Med; 2018; 80(2):167-173. PubMed ID: 29016549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional association between depression and type 2 diabetes mellitus in women.
    Pan A; Lucas M; Sun Q; van Dam RM; Franco OH; Manson JE; Willett WC; Ascherio A; Hu FB
    Arch Intern Med; 2010 Nov; 170(21):1884-91. PubMed ID: 21098346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus.
    Guo M; Mi J; Jiang QM; Xu JM; Tang YY; Tian G; Wang B
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):650-6. PubMed ID: 24862430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression-A Literature Review.
    Woo YS; Lim HK; Wang SM; Bahk WM
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment.
    Semenkovich K; Brown ME; Svrakic DM; Lustman PJ
    Drugs; 2015 Apr; 75(6):577-87. PubMed ID: 25851098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes.
    Swardfager W; Yang P; Herrmann N; Lanctôt KL; Shah BR; Kiss A; Oh PI
    Diabet Med; 2016 Apr; 33(4):529-36. PubMed ID: 26220364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.
    Rubin RR; Gaussoin SA; Peyrot M; DiLillo V; Miller K; Wadden TA; West DS; Wing RR; Knowler WC;
    Diabetologia; 2010 Aug; 53(8):1581-9. PubMed ID: 20422396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study.
    Kessing LV; Rytgaard HC; Ekstrøm CT; Knop FK; Berk M; Gerds TA
    Diabetes Care; 2020 Dec; 43(12):3050-3060. PubMed ID: 32978179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.
    Marrero DG; Ma Y; de Groot M; Horton ES; Price DW; Barrett-Connor E; Carnethon MR; Knowler WC;
    Psychosom Med; 2015 Apr; 77(3):303-10. PubMed ID: 25775165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
    Xing S; Calip GS; Leow AD; Kim S; Schumock GT; Touchette DR; Lee TA
    J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials.
    Moulton CD; Hopkins CWP; Ismail K; Stahl D
    Psychoneuroendocrinology; 2018 Aug; 94():91-103. PubMed ID: 29775878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in depressive symptoms and changes in lifestyle-related indicators: a 1-year follow-up study among adults with type 2 diabetes in Quebec.
    Messier L; Elisha B; Schmitz N; Gariepy G; Malla A; Lesage A; Boyer R; Wang J; Strychar I
    Can J Diabetes; 2013 Aug; 37(4):243-248. PubMed ID: 24070888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explaining psychological insulin resistance in adults with non-insulin-treated type 2 diabetes: The roles of diabetes distress and current medication concerns. Results from Diabetes MILES--Australia.
    Holmes-Truscott E; Skinner TC; Pouwer F; Speight J
    Prim Care Diabetes; 2016 Feb; 10(1):75-82. PubMed ID: 26150327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Promotes Anxiolytic and Antidepressant-Like Responses in Insulin-Resistant Mice by Decreasing Circulating Branched-Chain Amino Acids.
    Zemdegs J; Martin H; Pintana H; Bullich S; Manta S; Marqués MA; Moro C; Layé S; Ducrocq F; Chattipakorn N; Chattipakorn SC; Rampon C; Pénicaud L; Fioramonti X; Guiard BP
    J Neurosci; 2019 Jul; 39(30):5935-5948. PubMed ID: 31160539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of depression in diabetes is highest for young persons using oral anti-diabetic agents.
    Berge LI; Riise T; Fasmer OB; Lund A; Oedegaard KJ; Hundal O
    Diabet Med; 2012 Apr; 29(4):509-14. PubMed ID: 22133020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depressive disorders in diabetic patients].
    Manoudi F; Chagh R; Benhima I; Asri F; Diouri A; Tazi I
    Encephale; 2012 Oct; 38(5):404-10. PubMed ID: 23062454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.